Cited 3 times in
KASL clinical practice guidelines for management of autoimmune hepatitis 2022
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김자경 | - |
dc.contributor.author | 이현웅 | - |
dc.date.accessioned | 2024-01-03T00:30:53Z | - |
dc.date.available | 2024-01-03T00:30:53Z | - |
dc.date.issued | 2023-07 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/197276 | - |
dc.description.abstract | [No abstract available] | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Korean Association for the Study of the Liver | - |
dc.relation.isPartOf | CLINICAL AND MOLECULAR HEPATOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Antiviral Agents | - |
dc.subject.MESH | Hepatitis, Autoimmune* / diagnosis | - |
dc.subject.MESH | Hepatitis, Autoimmune* / drug therapy | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Liver Cirrhosis | - |
dc.title | KASL clinical practice guidelines for management of autoimmune hepatitis 2022 | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Korean Association for the Study of the Liver (KASL) | - |
dc.identifier.doi | 10.3350/cmh.2023.0087 | - |
dc.contributor.localId | A00852 | - |
dc.contributor.localId | A03292 | - |
dc.relation.journalcode | J00557 | - |
dc.identifier.eissn | 2287-285X | - |
dc.identifier.pmid | 37137334 | - |
dc.contributor.alternativeName | Kim, Ja Kyung | - |
dc.contributor.affiliatedAuthor | 김자경 | - |
dc.contributor.affiliatedAuthor | 이현웅 | - |
dc.citation.volume | 29 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 542 | - |
dc.citation.endPage | 592 | - |
dc.identifier.bibliographicCitation | CLINICAL AND MOLECULAR HEPATOLOGY, Vol.29(3) : 542-592, 2023-07 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.